PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Cardiovascular & Lipidology/MPO
Cardiovascular & LipidologyNeutrophil Degranulation & Oxidation

Serum Myeloperoxidase (MPO)

Heme peroxidase enzyme released by activated neutrophils during vascular inflammation.

Standard Range<400 pmol/L
Optimal Longevity<250 pmol/L
Measurement Unitpmol/L
Organ SystemNeutrophil Degranulation & Oxidation
Routine Panels:Cardiovascular Inflammatory ProfileACS Panel

Standard vs. Optimal Reference Rangespmol/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: pmol/L
pmol/L
Presets:
0 pmol/LOptimal Zone Target540 pmol/L
Optimal Longevity Zone(125 pmol/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<400 pmol/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

<250 pmol/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Generates hypochlorous acid, promoting LDL oxidation and fibrous cap thinning in plaque.

Differential Diagnosis

Elevated Levels (MPO High)

  • •Acute coronary syndrome
  • •Plaque rupture and erosion
  • •Systemic vasculitis
  • •Severe infection

Low Levels (MPO Low)

  • •Low neutrophil degranulation
  • •Optimal vascular quiescence

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Serum Myeloperoxidase (MPO) is critically involved in neutrophil degranulation & oxidation. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
Predicts near-term plaque rupture, myocardial infarction, and cardiovascular mortality independent of troponin.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for MPO
  • Targeted imaging or functional organ assessment related to neutrophil degranulation & oxidation
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Serum Myeloperoxidase - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]MPO in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:Cardiovascular Inflammatory ProfileACS Panel
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Myeloperoxidase (MPO) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Cardiovascular & Lipidology Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousLipoprotein-Associated Phospholipase A2 (Lp-PLA2)Cardiovascular & LipidologyNextAsymmetric Dimethylarginine (ADMA)Cardiovascular & Lipidology